Published Online
on March 23, 2005

A more recent version of this article appeared on March 29, 2005

This Article Full Text (PDF) All Versions of this Article: 111/12/1459    most recent 01.CIR.0000160874.48045.54v1 Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Teerlink, J. R. Articles by Massie, B. M. Search for Related Content PubMed Articles by Teerlink, J. R. Articles by Massie, B. M. Related Collections Cardio-renal physiology/pathophysiology

Submitted on ,
Accepted on ,

Nesiritide and Worsening of Renal Function. The Emperor’s New Clothes?

John R. Teerlink MD and Barry M. Massie MD^*

From the Section of Cardiology, San Francisco Veterans Affairs Medical Center, and the School of Medicine, University of California-San Francisco, San Francisco, Calif.

^* To whom correspondence should be addressed. E-mail: Barry.Massie{at}med.va.gov.

Key words: Editorials • heart failure • kidney • natriuretic peptides • drug approval

This article has been cited by other articles:

				A M. Richards Therapeutic potential of infused cardiac natriuretic peptides in myocardial infarction Heart, August 15, 2009; 95(16): 1299 - 1300. [Full Text] [PDF]

				C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease) Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons J. Am. Coll. Cardiol., December 2, 2008; 52(23): e143 - e263. [Full Text] [PDF]

				C. A. Warnes, R. G. Williams, T. M. Bashore, J. S. Child, H. M. Connolly, J. A. Dearani, P. del Nido, J. W. Fasules, T. P. Graham Jr, Z. M. Hijazi, et al. ACC/AHA 2008 Guidelines for the Management of Adults With Congenital Heart Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Develop Guidelines on the Management of Adults With Congenital Heart Disease): Developed in Collaboration With the American Society of Echocardiography, Heart Rhythm Society, International Society for Adult Congenital Heart Disease, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons Circulation, December 2, 2008; 118(23): e714 - e833. [Full Text] [PDF]

				A. S. Kesselheim, M. A. Fischer, and J. Avorn The rise and fall of Natrecor for congestive heart failure: implications for drug policy. Health Aff., July 1, 2006; 25(4): 1095 - 1102. [Abstract] [Full Text] [PDF]

				J. Sackner-Bernstein, K. D. Aaronson, G. Schreiner, P. A. April, and E. J. Topol Nesiritide--not verified. N. Engl. J. Med., October 6, 2005; 353(14): 1525 - 1527. [Full Text] [PDF]

				E. J. Topol Nesiritide -- Not Verified N. Engl. J. Med., July 14, 2005; 353(2): 113 - 116. [Full Text] [PDF]

				Does Nesiritide Increase Risks for Renal Failure and Death? Journal Watch Cardiology, May 6, 2005; 2005(506): 2 - 2. [Full Text]